United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium 6.5mmol) effervescent tablets bpc 1968 (actavis uk ltd - potassium bicarbonate; potassium acid tartrate - effervescent tablet - 500mg ; 300mg

Australia - English - Department of Health (Therapeutic Goods Administration)

the hydration pharmaceuticals trust - sodium chloride, quantity: 87.5 mg; sodium bicarbonate, quantity: 378 mg; potassium chloride, quantity: 149.2 mg (equivalent: potassium, qty 78.2 mg); citric acid, quantity: 672 mg; glucose, quantity: 1.62 g - tablet, effervescent - excipient ingredients: maltose; mannitol; steviol glycosides; pregelatinised maize starch; flavour - rapidly replaces fluid and electrolytes for the prevention and relief of dehydration caused by vomiting and diarrhea, fever, and heavy sweating, hot or dry conditions, vigorous exercise, excess alcohol consumption and other dehydrating conditions. hydralyte is specifically formulated to contain balanced essential electrolytes. it contains sodium - an electrolyte essential for water retention and rapid water uptake; and potassium - vital for nerve and muscle function. it also contains glucose to assist with the absorption of electrolytes and water. hydralyte is readily absorbed making it possible to rehydrate quickly. suitable for pediatric use. suitable for use during pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

the hydration pharmaceuticals trust - sodium chloride, quantity: 87.5 mg; sodium bicarbonate, quantity: 378 mg; potassium chloride, quantity: 149.2 mg (equivalent: potassium, qty 78.2 mg); citric acid, quantity: 672 mg; glucose, quantity: 1.62 g - tablet, effervescent - excipient ingredients: sucralose; maltose; mannitol; macrogol 6000; colour; flavour - rapidly replaces fluid and electrolytes for the prevention and relief of dehydration caused by vomiting and diarrhea, fever, and heavy sweating, hot or dry conditions, vigorous exercise, excess alcohol consumption and other dehydrating conditions. hydralyte is specifically formulated to contain balanced essential electrolytes. it contains sodium - an electrolyte essential for water retention and rapid water uptake; and potassium - vital for nerve and muscle function. it also contains glucose to assist with the absorption of electrolytes and water. hydralyte is readily absorbed making it possible to rehydrate quickly. suitable for pediatric use. suitable for use during pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

the hydration pharmaceuticals trust - sodium chloride, quantity: 87.5 mg; sodium bicarbonate, quantity: 378 mg; potassium chloride, quantity: 149.2 mg (equivalent: potassium, qty 78.2 mg); citric acid, quantity: 672 mg; glucose, quantity: 1.62 g - tablet, effervescent - excipient ingredients: sucralose; maltose; mannitol; macrogol 6000; colour; flavour - rapidly replaces fluid and electrolytes for the prevention and relief of dehydration caused by vomiting and diarrhea, fever, and heavy sweating, hot or dry conditions, vigorous exercise, excess alcohol consumption and other dehydrating conditions. hydralyte is specifically formulated to contain balanced essential electrolytes. it contains sodium - an electrolyte essential for water retention and rapid water uptake; and potassium - vital for nerve and muscle function. it also contains glucose to assist with the absorption of electrolytes and water. hydralyte is readily absorbed making it possible to rehydrate quickly. suitable for pediatric use. suitable for use during pregnancy.

Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; calcium chloride dihydrate 0.184 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 38.6 g/l; lactic acid as sodium 1.68 g/l - calcium chloride - calcium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure; severe water retention; severe electrolyte imbalance; drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - glucose monohydrate 3.56 g;  ;  ; potassium chloride 0.3 g;  ; sodium acid citrate 0.53 g; sodium chloride 0.47 g;   - powder for oral solution - active: glucose monohydrate 3.56 g     potassium chloride 0.3 g   sodium acid citrate 0.53 g sodium chloride 0.47 g   excipient: hydrated silica orange flavour saccharin sodium

Malta - English - Medicines Authority

baxter healthcare limited - glucose, sodium chloride - solution for infusion - glucose 5 percent weight/volume ; sodium chloride 0.45 percent weight/volume - blood substitutes and perfusion solutions

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - glucose monohydrate, quantity: 42.5 g/l (equivalent: glucose, qty 38.6 g/l); sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; calcium chloride dihydrate, quantity: 0.184 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; glucose monohydrate, quantity: 25 g/l (equivalent: glucose, qty 22.7 g/l); calcium chloride dihydrate, quantity: 0.184 g/l; sodium chloride, quantity: 5.38 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - glucose monohydrate, quantity: 15 g/l (equivalent: glucose, qty 13.6 g/l); sodium bicarbonate, quantity: 2.1 g/l; sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium lactate, quantity: 1.68 g/l; calcium chloride dihydrate, quantity: 0.184 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.